There has been great interest to Siglecs in AD pathogenesis since 2011 when genetic studies revealed that the CD33/Siclec-3 gene was a risk factor for AD pathology, as reviewed by Estus et al. [130]. The gene discussed is CD33; the disease is Alzheimer disease.